MedShift Tracks Record Procedure Volume During Second and Third Quarters of 2020

Share Article

MedShift has cultivated multiple tactics and strategies in order to provide the best offerings to benefit medical practices

MedShift is pleased to announce that during the late second quarter and early third quarter of 2020, the company's partnered medical practices reached a record high volume of delivered procedures. MedShift has cultivated multiple tactics and strategies in order to provide the best offerings to benefit medical practices. New devices and innovative marketing plans have proven to be key in helping practices grow and expand during this time, resulting in the record high treatment volumes for MedShift’s partnered medical practices.

MedShift offers a wide variety of medical devices ranging anywhere from skin tightening, to body contouring, and even hyperhidrosis. With practices reopening after being temporarily closed due to COVID-19, it was unknown how treatment volumes would recover. Medical practices have the ability to subscribe to a holistic program which includes MedShift’s services and a cosmetic device that not only benefits the practice by gaining new innovative technology, but also benefits the patients that are receiving the treatment.

When compared to the previous period, MedShift tracked treatment volume increases of 231.19%, displaying a strong recovery post COVID-19 reopening. The top selling procedures for the period include: Renuvion subdermal skin tightening, Emsculpt muscle toning and miraDry for underarm sweat reduction. Within a MedShift subscription, customers are able to benefit from social media services that not only highlight the capabilities of the device, but also enhance the practice overall by increasing awareness and procedure demand.

Practices are as busy as they have ever been and the aesthetic community is excited to be back in business. “We hope to continue the positive trends through 2020 and do not see patient demand slowing as we move into Q4 of 2020. We are grateful to the dedicated doctors and staff who are keeping pace, and MedShift is proud to assist in full and safe business resumption following mandated shutdowns,” said MedShift CEO, Brian Phillips.

About MedShift
MedShift, founded in 2015 in Charlotte, NC delivers a platform as a service to both medical device manufacturers as well as individual medical practices. Foundationally, MedShift enables access to the latest devices and technology to remain competitive and attract new business. MedShift has partnered with over 300 doctors in North America, Australia, and New Zealand to give practices the latest in cutting-edge treatment modalities, services, and systems.

MedShift is disrupting the traditional aesthetic device market by offering permanent placement, holistic subscription services for surgeons, physicians, and their business. MedShift’s broad portfolio of services for practices includes a portfolio of 24 leading aesthetic medical devices from nine manufacturers, an aesthetic eCommerce and subscription platform, in-house communications and marketing services, and inbound lead generation. For manufacturers, MedShift delivers a highly secure IoT platform consisting of both hardware and software assets allowing for real-time visibility, remote management, and big data modeling of entire medical device lineups. MedShift adds value across the manufacturer and provider spectrum and continues to empower robust integration with the leading brands and doctors in the industry. Additionally, in its first year of eligibility, MedShift ranked 185 on the 2020 Inc. 5000 list, leading as the 15th fastest growing health company in the United States.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Haleigh barnhardt
Visit website